Reply to: RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one

  1. Gonçalves, J.
  2. Santos, C.D.
  3. Fresco, P.
  4. Fernandez-Llimos, F.
Zeitschrift:
Revista Portuguesa de Cardiologia

ISSN: 2174-2030,  0870-2551

Datum der Publikation: 2024

Ausgabe: 43

Nummer: 4

Seiten: 221-222

Art: Brief

DOI: 10.1016/J.REPC.2023.10.005 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus